177 filings
6-K
IPHA
Innate Pharma
15 Apr 24
Innate Pharma Announces Advancement Of Sanofi-Developed Nk Cell Engager Sar443579 / Iph6101 Progressing To Phase 2 For Blood Cancer Patients
6:02am
6-K
IPHA
Innate Pharma
15 Apr 24
Current report (foreign)
6:00am
6-K
IPHA
Innate Pharma
10 Apr 24
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
6:51am
6-K
IPHA
Innate Pharma
21 Mar 24
Summary of Consolidated Financial Statements and Notes
9:20am
6-K
IPHA
Innate Pharma
21 Mar 24
Innate Pharma reports Full Year 2023 Financial Results and Business Update
6:01am
6-K
w5a38iutyzmzj
19 Mar 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:33am
6-K
rjsytafajqhe9jv
14 Mar 24
Innate Pharma Announces Conference Call And Webcast For Full Year 2023 Financial Results
7:00am
6-K
zdw6o3gr8ina3g
6 Mar 24
Current report (foreign)
6:00am
6-K
k4a89x4g14bpv
6 Mar 24
Current report (foreign)
6:00am
6-K
ql9ik
21 Feb 24
Innate Pharma Announces Its Participation To Upcoming Investor Conference
6:00am
6-K
vmamglp3u 2e1
6 Feb 24
Current report (foreign)
5:05pm
6-K
y36aoa9q v3ca8
12 Jan 24
Innate Pharma S.a. 6-K
6:00am
6-K
h528w
5 Jan 24
Innate Pharma S.a. 6-K
6:09am
6-K
7k9zt6 6t6w787j8l1
4 Jan 24
FDA lifts partial clinical hold on lacutamab clinical programFatal case related to disease progression and unrelated to the treatment
6:01am
6-K
bskwu0
4 Jan 24
Innate Pharma 6-K
6:00am
6-K
9urzfc3pt aw
20 Dec 23
Current report (foreign)
4:30pm
6-K
btv3m ajz681w
19 Dec 23
Innate Pharma S.a. 6-K
6:00am
6-K
x1pogqai2 n8b5xmtwd
18 Dec 23
Innate Pharma S.a. 6-K
11:40am
6-K
exo1bx0h
11 Dec 23
Innate Pharma S.a. 6-K
6:01am
6-K
1pdb56j w26q
11 Dec 23
Innate Pharma S.a. 6-K
6:00am